Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer

Stacy Moulder, John Moroney, Thorunn Helgason, Jennifer Wheler, Daniel Booser, Constance Albarracin, Phuong K. Morrow, Kimberly Koenig, Razelle Kurzrock

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer'. Together they form a unique fingerprint.